Literature DB >> 12519788

Change of conformation of the DNA-binding domain of p53 is the only key element for binding of and interference with p73.

Karim Bensaad1, Morgane Le Bras, Keziban Unsal, Sabrina Strano, Giovanni Blandino, Osamu Tominaga, Dany Rouillard, Thierry Soussi.   

Abstract

Xenopus p53 has biological and biochemical properties similar to those of human p53, except for optimal temperature. The frog protein is fully active at 30 degrees C and inactive at 37 degrees C, leading to a temperature-sensitive behavior similar to that of the human mutant p53Ala(143) and the murine mutant p53Val(135). Using hybrid proteins between human and Xenopus expressed from artificial p53 minigenes, we have been able to demonstrate that change of conformation of the DNA-binding domain is the major determinant of this heat sensitivity. It has been reported that some human tumor-derived p53 mutants can engage in a physical association with p73, thus inhibiting its transactivating properties. The mechanism of this association remains to be elucidated. The nature of the mutant p53 that can engage in this association also remains controversial. Using the unique opportunity of the temperature sensitivity of Xenopus p53, we demonstrate that binding of and interference with p73 require a change of conformation in the p53 protein. This interaction occurs through the DNA-binding domain of p53 only when it is in a denatured state. These results reinforce the notion that mutant p53 with a conformational change can act as a down-regulator of the p73 pathway in human cancer and could confer a selective advantage to the tumor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12519788     DOI: 10.1074/jbc.M208233200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Translating p53 into the clinic.

Authors:  Chit Fang Cheok; Chandra S Verma; José Baselga; David P Lane
Journal:  Nat Rev Clin Oncol       Date:  2010-10-26       Impact factor: 66.675

2.  Protein expression following gamma-irradiation relevant to growth arrest and apoptosis in colon cancer cells.

Authors:  Daniella Pfeifer; Asa Wallin; Birgitta Holmlund; Xiao-Feng Sun
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-06       Impact factor: 4.553

3.  Gain of function of mutant p53 by coaggregation with multiple tumor suppressors.

Authors:  Jie Xu; Joke Reumers; José R Couceiro; Frederik De Smet; Rodrigo Gallardo; Stanislav Rudyak; Ann Cornelis; Jef Rozenski; Aleksandra Zwolinska; Jean-Christophe Marine; Diether Lambrechts; Young-Ah Suh; Frederic Rousseau; Joost Schymkowitz
Journal:  Nat Chem Biol       Date:  2011-03-27       Impact factor: 15.040

Review 4.  Mutant p53: one name, many proteins.

Authors:  William A Freed-Pastor; Carol Prives
Journal:  Genes Dev       Date:  2012-06-15       Impact factor: 11.361

Review 5.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

Review 6.  Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?

Authors:  Danielly C F Costa; Guilherme A P de Oliveira; Elio A Cino; Iaci N Soares; Luciana P Rangel; Jerson L Silva
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

7.  Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay.

Authors:  Mattia Lion; Ivan Raimondi; Stefano Donati; Olivier Jousson; Yari Ciribilli; Alberto Inga
Journal:  PLoS One       Date:  2015-02-10       Impact factor: 3.240

8.  Evolutionary history of the p53 family DNA-binding domain: insights from an Alvinella pompejana homolog.

Authors:  Thierry Soussi; Andreas C Joerger; Qiang Zhang; Dimitrios-Ilias Balourdas; Bruno Baron; Alon Senitzki; Tali E Haran; Klas G Wiman
Journal:  Cell Death Dis       Date:  2022-03-07       Impact factor: 8.469

9.  Mutant p53 mediates survival of breast cancer cells.

Authors:  L Y Lim; N Vidnovic; L W Ellisen; C-O Leong
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

Review 10.  Oncogenic Intra-p53 Family Member Interactions in Human Cancers.

Authors:  Maria Ferraiuolo; Silvia Di Agostino; Giovanni Blandino; Sabrina Strano
Journal:  Front Oncol       Date:  2016-03-31       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.